These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27384386)

  • 1. Functional regulatory roles of microRNAs in atherosclerosis.
    Gao Y; Peng J; Ren Z; He NY; Li Q; Zhao XS; Wang MM; Wen HY; Tang ZH; Jiang ZS; Wang GX; Liu LS
    Clin Chim Acta; 2016 Sep; 460():164-71. PubMed ID: 27384386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?
    Wei Y; Nazari-Jahantigh M; Neth P; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):449-54. PubMed ID: 23324496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in atherosclerosis.
    Chen KC; Juo SH
    Kaohsiung J Med Sci; 2012 Dec; 28(12):631-40. PubMed ID: 23217354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic arterial remodeling: the good and bad of microRNAs.
    Wei Y; Schober A; Weber C
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1050-9. PubMed ID: 23396454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications.
    Cochain C; Zernecke A
    Curr Opin Lipidol; 2014 Oct; 25(5):380-6. PubMed ID: 25051497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.
    Aryal B; Suárez Y
    Vascul Pharmacol; 2019 Mar; 114():64-75. PubMed ID: 29551552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-specific regulatory mechanisms in atherosclerosis.
    Nazari-Jahantigh M; Egea V; Schober A; Weber C
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):35-41. PubMed ID: 25450610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review).
    Yu X; Li Z
    Int J Mol Med; 2014 Oct; 34(4):923-33. PubMed ID: 25197940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin.
    Li X; Yao N; Zhang J; Liu Z
    Mol Med Rep; 2015 Jul; 12(1):561-8. PubMed ID: 25738314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.
    Li Z; Zhao Y; Suguro S; Suguro R
    Oxid Med Cell Longev; 2023; 2023():2561509. PubMed ID: 37675243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of microRNAs as Anti-Atherosclerosis.
    Wang H; Shen S; Xuan Q; Wang X; Li X; Kong X
    Mini Rev Med Chem; 2015; 15(6):452-8. PubMed ID: 25807944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microvesicles containing microRNAs in vascular endothelial dysfunction.
    Shu Z; Tan J; Miao Y; Zhang Q
    J Cell Mol Med; 2019 Dec; 23(12):7933-7945. PubMed ID: 31576661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.
    Wei Y; Zhu M; Schober A
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of MicroRNAs in Atherosclerosis.
    Schober A; Weber C
    Annu Rev Pathol; 2016 May; 11():583-616. PubMed ID: 27193456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
    Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.
    Araldi E; Chamorro-Jorganes A; van Solingen C; Fernandez-Hernando C; Suarez Y
    Curr Vasc Pharmacol; 2015; 13(3):291-304. PubMed ID: 26156264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
    Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy.
    Gorabi AM; Ghanbari M; Sathyapalan T; Jamialahmadi T; Sahebkar A
    Curr Drug Targets; 2021; 22(15):1738-1749. PubMed ID: 33494668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small but smart: MicroRNAs orchestrate atherosclerosis development and progression.
    Santovito D; Egea V; Weber C
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt B):2075-2086. PubMed ID: 26738655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.